Garner Asset Management Corp Astrazeneca PLC Transaction History

Garner Asset Management Corp

  • $225 Million
  • Q3 2024

A detailed history of Garner Asset Management Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Garner Asset Management Corp holds 3,497 shares of AZN stock, worth $224,717. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,497
Previous 3,496 0.03%
Holding current value
$224,717
Previous $273,000 -0.0%
% of portfolio
0.12%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$76.67 - $87.62 $76 - $87
1 Added 0.03%
3,497 $273,000
Q2 2024

Aug 12, 2024
SELL
$66.81 - $80.83 $4,008 - $4,849
-60 Reduced 1.69%
3,496 $273,000
Q1 2024

May 16, 2024
BUY
$61.03 - $69.57 $3,783 - $4,313
62 Added 1.77%
3,556 $241,000
Q4 2023

Feb 14, 2024
SELL
$61.89 - $69.28 $42,085 - $47,110
-680 Reduced 16.29%
3,494 $235,000
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $25,875 - $28,608
-399 Reduced 8.73%
4,174 $283,000
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $103,117 - $111,819
-1,475 Reduced 24.39%
4,573 $327,000
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $21,344 - $24,200
-338 Reduced 5.29%
6,048 $420,000
Q4 2022

Feb 14, 2023
SELL
$54.21 - $70.44 $3,252 - $4,226
-60 Reduced 0.93%
6,386 $433,000
Q3 2022

Nov 14, 2022
SELL
$53.02 - $135.75 $42,097 - $107,785
-794 Reduced 10.97%
6,446 $354,000
Q2 2022

Jul 29, 2022
BUY
$59.26 - $71.14 $19,852 - $23,831
335 Added 4.85%
7,240 $478,000
Q4 2021

Jan 31, 2022
SELL
$54.02 - $63.83 $10,804 - $12,766
-200 Reduced 2.81%
6,905 $402,000
Q3 2021

Oct 29, 2021
SELL
$55.56 - $60.79 $1,111 - $1,215
-20 Reduced 0.28%
7,105 $427,000
Q1 2021

Apr 30, 2021
SELL
$47.16 - $54.44 $12,497 - $14,426
-265 Reduced 3.59%
7,125 $354,000
Q3 2020

Oct 30, 2020
SELL
$53.07 - $61.1 $26,535 - $30,550
-500 Reduced 6.34%
7,390 $405,000
Q1 2020

Apr 27, 2020
BUY
$37.79 - $51.33 $1,889 - $2,566
50 Added 0.64%
7,890 $352,000
Q2 2019

Jul 19, 2019
SELL
$37.28 - $41.68 $7,456 - $8,336
-200 Reduced 2.49%
7,840 $324,000
Q1 2019

Apr 23, 2019
SELL
$35.49 - $43.02 $19,519 - $23,661
-550 Reduced 6.4%
8,040 $325,000
Q3 2018

Oct 29, 2018
SELL
$34.76 - $39.72 $1,738 - $1,986
-50 Reduced 0.58%
8,590 $340,000
Q1 2018

Apr 27, 2018
SELL
$32.97 - $36.63 $17,968 - $19,963
-545 Reduced 5.93%
8,640 $0
Q4 2017

Jan 30, 2018
SELL
$32.09 - $34.78 $3,209 - $3,478
-100 Reduced 1.08%
9,185 $319,000
Q2 2017

Aug 14, 2017
BUY
N/A
9,285
9,285 $317,000

Others Institutions Holding AZN

# of Institutions
1,359
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Garner Asset Management Corp Portfolio

Follow Garner Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garner Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Garner Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email